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Streptococcus suis serotype 2 is an emerging zoonotic pathogen and is the main cause of acute bacterial meningitis in adult patients in
Vietnam. We developed an internally controlled real-time PCR for detection of S. suis serotype 2 in cerebrospinal fluid (CSF) samples
targeted at the cps2J gene. Sensitivity and specificity in culture-confirmed clinical samples were 100%. The PCR detected S. suis serotype 2
infection in 101 of 238 (42.4%) prospectively collected CSF samples, of which 55 (23%) were culture positive. Culture-negative but PCR-
positive CSF samples were significantly associated with the use of antimicrobial agents before admission. S. suis serotype 2 infection was
more common than infections with Streptococcus pneumoniae and Neisseria meningitidis combined. Our results strikingly illustrate the
additional diagnostic value of PCR in patients who are pretreated with antimicrobial agents and demonstrate the extremely high prevalence of
S. suis infections among Vietnamese adult patients with bacterial meningitis.
© 2011 Elsevier Inc. Open access under CC BY license. Keywords: Bacterial meningitis; Streptococcus suis serotype 2; CSF; Real-time PCR1. Introduction
Streptococcus suis is an emerging zoonotic human
pathogen. S. suis infection is acquired through exposure to
contaminated pigs or pig meat. Healthy pigs can carry
multiple serotypes of S. suis in their nasal cavities, tonsils,
and upper respiratory, genital, and alimentary tracts. Based
on differences in antigenic properties of the polysaccharide
capsule, 33 serotypes have been distinguished to date, of
which only a limited number are responsible for infections in
pigs, including serotypes 1 to 9 and 14. Serotype 2 is⁎ Corresponding author. Tel.: +31-20-5667800; fax: +31-20-5669557.
E-mail address: schultsz@gmail.com (C. Schultsz).
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Open access under CC BY license. considered to be the most pathogenic for both humans and
pigs and is the single most common serotype found in human
infection (Gottschalk et al., 2007).
Over the past few years, the number of reported S. suis
infections in humans has increased substantially, with most
cases originating in Southeast Asia where there is a high density
of pigs. Increased awareness, particularly following the
occurrence of an outbreak of human and pig infection in the
Sichuan province in China in 2005, has likely contributed to
this increase in reported human infections (Tang et al., 2006; Ye
et al., 2006). Meningitis and septicemia are the most common
clinical manifestations of human S. suis infection; hearing loss
is a frequent complication (Wertheim et al., 2009a).
Although S. suis can be cultured from cerebrospinal fluid
(CSF) or blood samples with use of standard microbiological
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cultures are misidentified as Streptococcus species, alpha-
hemolytic or viridans streptococci, Enterococcus faecalis,
Aerococcus viridans, or Streptococcus pneumoniae (Donsa-
kul et al., 2003; Lutticken et al., 1986). Furthermore, culture
results can be negative as a result of antibiotic use before the
collection of specimens.
During a randomized placebo-controlled clinical trial on
the adjuvant use of dexamethasone in adult patients with
bacterial meningitis, carried out at the Hospital for
Tropical Diseases in Ho Chi Minh City, Vietnam, S. suis
serotype 2 was found to be the most common pathogen
isolated from CSF cultures (Nguyen et al., 2007). As up to
60% of patients had used antimicrobial agents before
submission to the hospital, and culture results were
negative for 50% of patients (Nguyen et al., 2007), an
internally controlled diagnostic real-time PCR was set up
for detection of S. suis serotype 2 to further study the
importance of this pathogen in patients with bacterial
meningitis in this region. Here we report the design of this
method and its prospective evaluation.2. Materials and methods
2.1. Sample collection
This study was performed at the Hospital for Tropical
Diseases, a tertiary referral hospital for infectious diseases.
CSF samples were collected and stored as part of a
randomized placebo-controlled clinical trial carried out at
the Hospital for Tropical Diseases between November
1996 and May 2005 (Nguyen et al., 2007). CSF samples
were sent for biochemical and microbiological investiga-
tions, and an aliquot was stored at −70 °C in a dedicated
freezer on the ward. These samples were studied
retrospectively. CSF samples were prospectively collected
from all consecutive adult patients (age ≥15 years)
presenting with fever and neck stiffness and/or altered
consciousness at the Hospital for Tropical Diseases from
May 2006 until June 2009, and were aliquoted immedi-
ately after lumbar puncture on the ward. Aliquots were
sent to the biochemistry and microbiology laboratories for
immediate processing and analyses. A separate aliquot was
sent to the molecular diagnostics laboratory, where
samples where stored for a maximum of 48 h at −70 °C
until testing (prospective study). Standard measures for
prevention of PCR contamination are operational at the
molecular diagnostic laboratory, including a unidirectional
workflow in physically separated laboratories for reagent
preparation, nucleic acid extraction, and amplification and
analysis, respectively.
Demographic, clinical, and laboratory data were recorded
for all patients. The study was approved by the ethical review
boards of the Hospital for Tropical Diseases and the
University of Oxford (OXTREC).2.2. Bacterial culture
All CSF samples were spun down and a Gram stain was
made. The pellet was inoculated on blood and chocolate agar
plates and in brain heart infusion broth for enrichment. Plates
were incubated at 37 °C in 5% CO2 for 18 h. The broth was
incubated aerobically and subcultured if growth was present.
Bacteria were identified using standard identification meth-
ods. S. suiswas identified on the basis of colony morphology,
negative catalase reaction, optochin resistance, and APIStrep
(Biomerieux, Ho Chi Minh City, Vietnam). Serotyping was
performed by slide agglutination with use of specific antisera
(Statens Serum Institute, Copenhagen, Denmark).
Blood culture was performed using the BACTEC 9050
system, and positive culture results were identified as
described above.
2.3. Primers and probes
Primers and probe for S. suis serotype 2 real-time PCR were
designed using Primer Express Software and BLAST analysis,
and were targeted at the cps2J gene (Smith et al., 1999, 2000),
which is part of the operon encoding the serotype 2 and serotype
1/2 specific polysaccharide capsule of S. suis. Primers cps2JF
(GGTTACTTGCTACTTTTGATGGAAATT) and cps2JR
(CGCACCTCTTTTATCTCTTCCAA) and probe (FAM-
TCAAGAATCTGAGCTGCAAAAGTGTCAAATTGA-
TAMRA) were used for amplification and detection of an
88-bp amplicon. Primers and probes for real-time PCR for
detection of S. pneumoniae, Haemophilus influenzae type b,
and N. meningitidis were as described by Corless et al. (2001)
except that for all probes, FAM (6-carboxyfluorescein) and
TAMRA were used as reporter and quencher, respectively.
Primers and probe for detection of internal control (IC)
DNA (see below) were as described by van Doornum et al.
(2003). The IC probe was labeled with Cy5 and BHQ1.
2.4. Internal control
The efficiency of the DNA extraction and the amplifi-
cation during the PCR was monitored using an IC,
consisting of a pretest determined concentration of Phocid
herpesvirus. IC was added to all samples before DNA
extraction, as described by van Doornum et al. (2003).
Concentration of IC was such that after efficient extraction
and amplification, a Cy5 cycle threshold value (Ct value)
between 33 and 37 should be expected for the IC-specific
PCR reaction. Higher Ct values or negative results were
interpreted as loss of DNA during extraction or inhibition of
the PCR assay, in which case extraction and amplification
were repeated. PhHV was kindly provided by M. Schutten
(EMC, Rotterdam, the Netherlands).
2.5. DNA extraction of pure cultures and CSF samples
A 100-μL aliquot of a bacterial suspension or of unspun
CSF was treated with 0.1 volume of prelysis buffer (1%
SDS, 5% Tween 20, and 5% Sarkosyl in 1× TE) at 37 °C for
able 1
omparative analytical sensitivities of S. suis serotype 2 primers in the
resence and absence of IC DNA
DNA Mean Ct value at the following bacterial concentration
105 CFU/mL 104 CFU/mL 103 CFU/mL
resent 29.99 33.25 36.78
bsent 30.21 33.19 36.80
able 2
ensitivity and specificity of S. suis serotype 2 PCR on culture-confirmed
SF samples, retrospective study (A) and prospective study (B)
. No. of
samples
PCR
positive
PCR
negative
. suis serotype 2 114 114 0
. suis serotype 14 1 0 1
. meningitidis 11 0 11
eisseria species 1 0 1
. pneumoniae 50 0 50
. influenzae 5 0 5
treptococcus bovis 2 0 2
treptococcus agalactiae 1 0 1
treptococci, viridans group 6 0 6
taphylococcus aureus 2 0 2
scherichia coli 8 0 8
lebsiella pneumoniae 10 0 10
roteus mirabilis 1 0 1
seudomonas aeruginosa 1 0 1
otal 213 114 99
. No. of
samples
No. of PCR
positive
No. of PCR
negative
. suis serotype 2 55 55 0
. suis serotype 14 2 0 2
. suis, untypeable 1 0 1
. meningitidis 4 0 4
. pneumoniae 16 0 16
. influenzae 1 0 1
treptococcus agalactiae 1 0 1
onhemolytic streptococci 1 0 1
taphylococcus aureus 1 0 1
scherichia coli 3 0 3
lebsiella pneumoniae 2 0 2
cinetobacter spp. 1 0 1
nterococcus avium 1 0 1
isteria spp. 4 0 4
almonella spp. 1 0 1
otal 94 55 39
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was added to the sample, and DNA was extracted by manual
extraction (retrospective study) or automated extraction
using the EasyMag extraction system (BioMerieux, Ho Chi
Minh City, Vietnam), according to manufacturer's instruc-
tions (prospective study). The manual extraction was
performed as described by Boom et al. (1999), using lysis
buffer L7 that contains 1 mg/mL α-casein. The DNA was
eluted in a final volume of 100 μL.
2.6. PCR components and amplification
The final PCR volume was 25 μL. The PCRmix consisted
of 5 mmol/L MgCl2, 0.2 mmol/L each deoxynucleoside
triphosphates dATP, dCTP, dGTP, dUTP, and 1 U of Hot
Start Taq DNA polymerase (Qiagen, Hanoi, Vietnam) to
which 5 μL of extracted DNA was added. Final concentra-
tions of the 2 primers and probe sets for target and ICwere 0.4
μmol/L of each primer and 0.1 μmol/L of each probe. PCR
amplification conditions consisted of 15 min at 95 °C and 45
cycles of 30 s at 95 °C, 30 s at 60 °C, and 30 s at 72 °C in a
Chromo 4 Real-time PCR system (Biorad, Ho ChiMinh City,
Vietnam). Negative (no-template) controls of both extraction
and PCR were included in each run.
The PCR was considered positive if negative controls
were all negative and a FAM signal with a Ct value of ≤40
could be obtained from the sample. A PCR was considered
negative if negative controls were all negative, and the IC
showed a Cy5 Ct value within the expected range, and a
FAM signal could not be obtained from the sample or the Ct
value was N40. Any PCR that yielded a FAM Ct value N35
was repeated in duplicate for confirmation. The PCR was
considered indeterminate if the IC showed a Cy5 Ct value
outside of the expected range and a FAM signal could not be
obtained or the Ct value was N40, in which case DNA
extraction and the PCR were repeated as described before.
The sensitivity and specificity of the PCR assay were
determined on the basis of PCR results in bacterial culture-
confirmed samples. PCR for S. suis serotype 2 was run on all
culture-positive samples, including those growing S. suis, S.
pneumoniae, N. meningitidis, H. influenzae, or other
pathogens (Tables 2 and 3).
2.7. Analytical sensitivity
To determine the detection limit of the assay, including
the DNA extraction, a 10-fold serial dilution of a 0.5
McFarland suspension of S. suis serotype 2 strain 31533,
kindly provided by M. Gottschalk (Montreal, Canada), was
prepared in Todd Hewitt Broth. Fifty microliters of each
dilution was spread out on blood agar plates in triplicate and
incubated at 37 °C in 5% CO2 overnight for colony counting.
A 100-μL volume of each dilution was used for DNA
extraction in triplicate, in the absence and presence of IC.
Five microliters of DNA was used for real-time PCR, as
described above.T
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The PCR assay detected S. suis serotype 2 at a
concentration of 2 × 102 colony-forming units (CFUs) per
milliliter, resulting in an analytical sensitivity of 1–5 CFUs
per reaction. This analytical sensitivity did not vary in the
presence or absence of IC DNA (Table 1).
Sensitivity of the PCR was 100% when tested against 114
stored samples from culture-confirmed cases of meningitis
with S. suis serotype 2 (Table 2A). The PCR was negative inT
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Table 3
Demographic, clinical, and outcome characteristics of 248 patients included
in prospective study
Characteristics Frequency (%) N = 248
Age (years), median (interquartile range) 46.5 (34–59)
Sex, male 181 (73.0)
Occupation
Farmer 79 (31.9)
Worker 35 (14.1)
Student 4 (1.6)
Seller 22 (8.9)
Occupation related to pigs
✓ Butcher 7 (2.8)
✓ Slaughterer 6 (2.4)
✓ Pig breeder 4 (1.6)
Housewife 14 (5.7)
Other 32 (12.9)
No job 45 (18.2)
Underlying diseases/predisposing factors
Diabetes mellitus 19 (7.7)
Alcoholism 18 (7.3)
Otitis media 6 (2.4)
Splenectomy 2 (0.8)
Head trauma 26 (10.5)
Cardiovascular diseasesa 17 (6.9)
Pig/pork exposuresb 51 (20.6)
HIV/AIDS 4 (1.6)
Used intravenous antibiotics before admission 157 (63.3)
a Valvular heart diseases, atrial fibrillation.
b Occupation related to pig/pork, eating pig's intestines and fresh
blood, etc.
Table 4
Results of Gram stain, culture, and real-time PCR for detection of S. suis serotype 2
and blood culture, prospective study
No. of positive specimens
CSF Gram stain
(n = 247)
CSF culture
(n = 247)
S. suis serotype 2 50 61a
S. suis serotype 14 1 2
S. suis untypeable 1 1
N. meningitidis 4 4
S. pneumoniae 9 16
H. influenzae, nontypeable 0 1
Streptococcus bovis 1 1
Streptococcus agalactiae 2 1
β-Hemolytic streptococci 0 0
Nonhemolytic streptococci 0 1
Staphylococcus aureus 1 1
Escherichia coli 1 3
Klebsiella pneumoniae 2 4
Acinetobacter spp. 0 1
Enterococcus avium 0 1
Listeria spp. 1 4
Salmonella spp. 0 1
Total 73 103
nd = not done.
a CSF samples were unavailable for PCR for 6 patients.
b S. pneumoniae-specific PCR was negative in 1 patient; CSF sample unavai
c CSF sample unavailable for PCR.
d CSF sample unavailable for PCR for 2 patients.
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pathogens, including S. suis of other serotypes (100%
specificity, Table 2A). All PCR-negative samples gave Ct
values for the IC within the expected range.
Stored CSF samples that were culture positive for
S. pneumoniae, N. meningitidis, and H. influenzae type b
were also subjected to real-time PCR for specific detection
of these pathogens. Of 50 samples culture positive for
S. pneumoniae, 48 were positive in the PCR for detection of
S. pneumoniaeDNA, while all 11 samples culture positive for
N. meningitidis and all 4 samples positive for H. influenzae
type b were also positive in the respective specific PCRs.
During the study period, we admitted 248 consecutive
patients with a clinical suspicion of bacterial meningitis.
Demographic, clinical, and outcome characteristics of these
248 patients are shown in Table 3. CSF samples from 238
patients were prospectively studied using bacterial culture
and real-time PCR for detection of S. suis serotype 2,
N. meningitidis, H. influenzae type b, and S. pneumoniae. A
lumbar puncture was contraindicated in one patient because
of risk of brain herniation. CSF samples were erroneously
not sent for PCR analysis for the remaining 9 patients.
All 55 S. suis serotype 2 culture-positive samples
collected prospectively on admission were also positive in
the S. suis serotype 2-specific PCR. The admission CSF
sample of one patient with culture-confirmed S. suis serotype
2 meningitis was not available for PCR analysis and PCR
result of the second CSF sample from this patient (collected, S. pneumoniae, H. influenzae type b, and N. meningitidis on CSF samples,
CSF PCR
(n = 238)
Blood culture
(n = 222)
Total
(N = 248)
101a 34 107
0 1 2
0 0 1
11 2 11
37b 8 39
0 1 1
ndc 0 1
0 2 2
0 1 1
0 1 1
0 3 3
0 2 3
0d 1 4
0 0 1
0 0 1
0 2 4
0 0 1
149 58 183
lable for PCR for 1 patient.
Table 5
Result of CSF investigations for S. suis serotype 2, S. pneumoniae,
N. meningitidis
Antimicrobial
agents before
admission
Result of CSF investigations for S. suis serotype 2,
S. pneumoniae, N. meningitidis
Culture
positive,
no. (%)
PCR
positive,
no. (%)
Median
Ct valuea
(range)
P
valueb
Used 34/98 (34.7) 97/97 (100) 27.78 (15.39–38) b0.001
Not used 39/47 (82.0) 42/43 (97.7) 24.66 (19.76–31.24)
Unknown 8/11 (72.7) 10/11 (90.9) 24.57 (20.76–29)
a Cycle treshold value of real-time PCR.
b Difference between Ct values for antimicrobial agents used versus not
used, Wilcoxon rank-sum test.
able 6
haracteristics of patients with S. suis meningitis confirmed by CSF and/or
lood culture and PCR, or only confirmed by PCR
haracteristics CSF and/or blood
culture and PCR
positive (n = 67)
PCR
positive
(n = 43)
P
valuea
eneral information
Age, median (IQR) 48 (38–56) 53 (45–61) 0.026
Male sex (n, %) 57 (85.1) 34 (79.1) 0.416
Residence (rural) (n, %) 53 (79.1) 32 (74.41) 0.567
nderlying diseases and exposure
Diabetes mellitus (n, %) 1 (1.5) 6 (13.0) 0.010
Alcoholism (n, %) 8 (11.9) 2 (4.7) 0.194
Pig exposure (n, %) 26 (38.8) 14 (32.6) 0.506
linical manifestations
Days of illness, median
(IQR)
3 (3–5) 5 (4–7) 0.004
Antimicrobial therapy
before admission (n, %)
35 (53.2) 38 (88.4) b0.001
Fever (n, %) 65 (97.0) 42 (97.7) 0.522
Headache (n, %) 67 (100) 42 (97.7) 0.391
Nausea/vomiting (n, %) 49 (73.1) 27 (62.8) 0.252
Neck stiffness (n, %) 61 (91.0) 40 (93.0) 1.000
Glasgow Coma Score,
median (IQR)
12 (9–14) 13 (9–15) 0.159
Tinnitus (n, %) 50 (74.6) 27 (62.8) 0.118
Deafness (n, %) 19 (28.4) 11 (25.6) 0.714
Skin injuries (n, %) 18 (26.9) 13 (30.2) 0.702
Herpes labialis (n, %) 29 (43.3) 21 (48.8) 0.568
aboratory investigations median (IQR)
▪ Blood
White blood cells
(103/L)
18 000
(12 400–23 000)
16 840
(12 600–23 550)
0.941
Neutrophil (%) 88 (83–91) 86.3 (80.3–90) 0.131
▪ CSF
White cells (103/L) 1570
(760–3480)
1340
(340–2900)
0.153
Neutrophil (%) 86 (74–91) 70 (49–85) 0.002
Protein (g/L) 1.6 (1.3–2) 1.63 (1.2–2) 0.402
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serotype 2 specific PCR was negative in all 39 samples,
which were culture confirmed with other bacterial patho-
gens, including S. suis of other serotypes (Table 2B).
S. suis was the most commonly identified pathogen
(Table 4). PCR for S. suis serotype 2 was positive in 101 of
238 (42.4%) samples, of which 55 (23.1%) were culture
positive. S. pneumoniae and N. meningitidis were detected
in 37 (15.5%) and 11 (4.6%) patients of which 16 (6.7%) and
4 (1.7%) were culture positive, respectively. Listeria species
were cultured from CSF of 4 patients. Infections with
multiple bacterial species were not detected. All samples
gave the expected results for the IC. Bacterial pathogens
were detected in 183 of 248 (73.8%) adult patients suspected
of bacterial meningitis when combining results of Gram
stain, bacterial culture and PCR on CSF, and blood culture.
CSF was significantly more often culture negative in
patients who were pretreated with antimicrobial agents
before admission (Table 5). In contrast, detection rates by
PCR were similar in patients who were pretreated and those
who were not, although Ct values were significantly higher
in patients who had received antimicrobial agents before
collection of the CSF sample (Table 5). We compared
characteristics between patients who were only positive by
PCR in CSF and those of whom CSF or blood samples were
also culture positive (Table 6). Patient characteristics related
to exposure and clinical presentation were highly similar
between the two groups, with the exception of a higher age
and a higher prevalence of diabetes mellitus in patients who
were PCR-positive only. In contrast, the median duration of
illness was significantly longer and pretreatment with
antimicrobial agents significantly more common in patients
who were PCR-positive only. This was also reflected by
lower CSF neutrophil counts, higher CSF glucose levels, and
lower CSF lactate levels in the latter patients (Table 6).CSF/blood glucose ratio 0.24 (0.15–0.31) 0.40 (0.29–0.5) b0.001
Lactate (mmol/L) 11.2 (6.8–15.7) 5.73 (4.4–8.3) b0.001
utcome (survival) 67 (100) 40 (100)b
a Determined using Fisher exact test or Wilcoxon rank-sum test, as
ppropriate.
b Three patients were transferred to other hospitals and their outcomes
re unknown.4. Discussion
Human infections with S. suis are increasingly reported
from various geographical areas. S. suis serotype 2 is themost common pathogen detected in adult patients with acute
bacterial meningitis in Vietnam (Mai et al., 2008; Wertheim
et al., 2009b). While S. suis is not difficult to culture on
blood agar plates supplemented with 5% CO2, CSF cultures
may remain negative because of prior use of antimicrobial
agents or low bacterial load. We developed a highly sensitive
and specific real-time PCR for detection of S. suis serotype 2
in CSF. We designed primers targeted at the cps2J gene,
which encodes a putative glycosyl transferase involved in the
formation of the serotype 2 capsular polysaccharide. This
gene was also used by other investigators as a target for
conventional PCR for specific detection of S. suis serotype 2
in tonsillar and other pig samples (Wisselink et al., 2002).
The cps2J gene is present in strains of serotype 2 and ofT
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serotype 2 in all culture-positive CSF samples, and none
contained serotype 1/2. To our knowledge, S. suis serotype
1/2 infection has never been reported in humans. So far,
serotype 2 is the cause of more than 95% of reported human
S. suis infections (Wertheim et al., 2009a), and only sporadic
single cases of patients infected with S. suis serotypes 1, 4,
and 16 have been described (Nghia et al., 2008; Wertheim
et al., 2009a). However, one patient in our retrospective
analysis and 2 patients in the prospective analysis were
infected with S. suis serotype 14. As expected, these samples
were negative in the PCR. While the absolute number of
patients reported with S. suis serotype 14 infection is still
very low, this serotype appears to contribute consistently to
the infectious burden of S. suis as reported in Thailand
(Kerdsin et al., 2009) and also observed in our study. While
serotype 2 by far remains the predominant strain associated
with human infection at present, inclusion of additional
primer sets for detection of serotype 14 or generic detection of
S. suis may therefore be considered in the future.
Our assay showed 100% sensitivity against samples that
were culture positive for S. suis serotype 2, while analysis
of CSF samples that were culture or PCR-positive for
other pathogens than S. suis serotype 2, including
S. pneumoniae, N. meningitidis, and H. influenzae, indi-
cated 100% specificity of the assay. Thus, in a tertiary
referral setting in southern Vietnam, the positive and
negative predictive values of the test are 100%. Results of
real-time PCR for specific detection of S. pneumoniae,
N. meningitidis, and H. influenzae on samples studied
retrospectively, which had been culture positive for these
pathogens, showed that bacterial DNA was still detectable
in 97% of samples indicating that the bacterial DNA was
not affected by storage.
Prospective evaluation showed a striking additional
diagnostic value of the S. suis serotype 2 PCR over culture,
further strengthening observations that the prevalence of
S. suis infections among Vietnamese patients with bacterial
meningitis is extremely high. The diagnostic yield increased
by 84% for patients with S. suis serotype 2 infection when
using PCR. Similar differences in detection rates between
culture and PCR were found for S. pneumoniae and
N. meningitidis. In large part, these differences can be
explained by the use of antimicrobial agents before
admission and collection of specimens. In our study, overall
63.3% of patients had received antibiotics before admission,
and this proportion was significantly higher in patients with
culture-negative CSF samples. Furthermore, bacterial loads
as assessed by Ct values in our PCR were significantly lower
in pretreated patients. However, while PCR is clearly an
important tool in the diagnosis of bacterial meningitis, it
should not replace Gram stain and bacterial culture, given the
need of a rapid presumptive diagnosis and antimicrobial
susceptibility data in the treatment of this life-threatening
disease. In addition, the pathogens that can be detected using
PCR generally do not cover the full spectrum of potentialcauses of bacterial meningitis, indicating the continued need
of bacterial culture.
S. suis was detected at much higher rates than
S. pneumoniae and N. meningitidis in our study population.
S. suis is increasingly recognized as an important cause of
bacterial meningitis in adults, not only in Vietnam but also in
China, Thailand, Singapore, and other countries in the region,
while sporadic cases are reported worldwide. Risk factors for
S. suis infection include (occupational) exposure to pigs and
pig products. Consumption of undercooked pork products
is increasingly being suggested as an additional risk factor
for S. suis infection (Wertheim et al., 2009a). The mortality
of S. suis infection varies with the clinical presentation, with
the lowest mortality in patients with meningitis and the highest
mortality in those presenting with a streptococcal toxic shock-
like syndrome (Wertheim et al., 2009a). Resistance to
penicillin in S. suis is extremely rare. All cultured strains in
our study were sensitive to penicillin and ceftriaxone, which
are the drugs of choice for treatment of S. suis meningitis.
S. suis meningitis is commonly associated with neurologic
sequelae, in particular hearing loss, which can be found in up to
60% of cases (Mai et al., 2008). To reliably determine the
burden of disease caused by S. suis infection, while taking into
account that over-the-counter sales of antimicrobial agents is
common in regions where S. suis infections predominantly
occur, the availability of sensitive and specific diagnostic tools
to detect S. suis infections is extremely important. To our
knowledge, this is the first prospective study on the molecular
diagnosis of S. suis infections in humans.
In conclusion, we developed a highly sensitive and
specific real-time PCR for detection of S. suis serotype 2 in
CSF, which is now routinely used in a setting where human
S. suis serotype 2 infection is endemic.
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